Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Fava

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Current Drug Targets|August 7, 2015
New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin CancerPaola Savoia, Ottavio Cremona, Paolo Fava
Current Drug Targets|January 14, 2016
Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ RecipientsPaola Savoia, Andrea Ranghino, Paolo Fava
Human Vaccines & Immunotherapeutics|February 19, 2016
Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity managementPaola Savoia, Chiara Astrua, Paolo Fava
International Journal of Molecular Sciences|April 3, 2019
Targeting the ERK Signaling Pathway in MelanomaPaola Savoia, Paolo Fava, Filippo Casoni, et al.
European Journal of Dermatology : EJD|January 7, 2017
A study of melanoma in Eastern European migrants in ItalyChiara Astrua, Paolo Fava, Matteo Brizio, et al.
International Journal of Molecular Sciences|August 23, 2016
Inflammatory Cutaneous Diseases in Renal Transplant RecipientsPaola Savoia, Giovanni Cavaliere, Elisa Zavattaro, et al.
Dermatology Reports|March 20, 2025
New and emerging therapies in cutaneous T-cell lymphomaGabriele Roccuzzo, Nicole Macagno, Silvia Giordano, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 11, 2009
Zosteriform cutaneous metastases: a literature meta-analysis and a clinical report of three melanoma casesPaola Savoia, Paolo Fava, Tommaso Deboli, et al.
Seminars in Cancer Biology|March 5, 2023
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studiesGabriele Roccuzzo, Giovenale Moirano, Paolo Fava, et al.
Dermatologic Therapy|September 28, 2010
Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruptionPaolo Fava, Pietro Quaglino, Maria Teresa Fierro, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Current Drug Targets|August 7, 2015
New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin CancerPaola Savoia, Ottavio Cremona, Paolo Fava
Current Drug Targets|January 14, 2016
Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ RecipientsPaola Savoia, Andrea Ranghino, Paolo Fava
Human Vaccines & Immunotherapeutics|February 19, 2016
Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity managementPaola Savoia, Chiara Astrua, Paolo Fava
International Journal of Molecular Sciences|April 3, 2019
Targeting the ERK Signaling Pathway in MelanomaPaola Savoia, Paolo Fava, Filippo Casoni, et al.
European Journal of Dermatology : EJD|January 7, 2017
A study of melanoma in Eastern European migrants in ItalyChiara Astrua, Paolo Fava, Matteo Brizio, et al.
International Journal of Molecular Sciences|August 23, 2016
Inflammatory Cutaneous Diseases in Renal Transplant RecipientsPaola Savoia, Giovanni Cavaliere, Elisa Zavattaro, et al.
Dermatology Reports|March 20, 2025
New and emerging therapies in cutaneous T-cell lymphomaGabriele Roccuzzo, Nicole Macagno, Silvia Giordano, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 11, 2009
Zosteriform cutaneous metastases: a literature meta-analysis and a clinical report of three melanoma casesPaola Savoia, Paolo Fava, Tommaso Deboli, et al.
Seminars in Cancer Biology|March 5, 2023
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studiesGabriele Roccuzzo, Giovenale Moirano, Paolo Fava, et al.
Dermatologic Therapy|September 28, 2010
Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruptionPaolo Fava, Pietro Quaglino, Maria Teresa Fierro, et al.
Pageof 8